Although the steady-state level of SUMOylation played an essential role in the homeostasis and function of lymphocytes, the relationship between dysregulated SUMOylation in lymphocytes and the resistance to anti-PD-1 immunotherapy in lung cancer was still unclear (45–48). This evidence concerns the gene PDCD1 and lung carcinoma.